Better survival is observed in cervical cancer patients positive for specific anti-glycan antibodies and receiving brachytherapy.

CONCLUSIONS: Better PFS and DSS are observed in cervical cancer patients that are positive for specific antiglycan antibodies and received brachytherapy.
PMID: 31955861 [PubMed - as supplied by publisher]

Source: Gynecologic Oncology - January 15, 2020 Category: Cancer & Oncology Authors: Purohit S, Ferris DG, Alvarez M, Tran PMH, Tran LKH, Mysona DP, Hopkins D, Zhi W, Dun B, Wallbillich JJ, Cummings RD, Wang PG, She JX Tags: Gynecol Oncol Source Type: research